Publikationen, an denen er mitarbeitet Carmen Mora Fernández (70)

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

  4. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

    Antioxidants, Vol. 12, Núm. 2

  5. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  6. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

  7. Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study

    Frontiers in Cardiovascular Medicine, Vol. 10

  8. Targeting inflammation to treat diabetic kidney disease: the road to 2030

    Kidney International, Vol. 103, Núm. 2, pp. 282-296

  9. The Value of Klotho in Kidney Transplantation

    Transplantation, Vol. 107, Núm. 3, pp. 616-627

2022

  1. Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  2. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

  3. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

  4. Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease

    Nutrients, Vol. 14, Núm. 22

  5. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. KLOTHO gene promoter methylation in the vasculature is related to inflammation in human atherosclerosis

    Atherosclerosis, Vol. 331, pp. e222

  2. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

    Scientific Reports, Vol. 11, Núm. 1

  3. Nefropatía diabética

    Nefrología pediátrica (Ediciones de la Universidad de Oviedo), pp. 427-434

  4. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia

    Rheumatology (Oxford, England), Vol. 60, Núm. 1, pp. 371-379

2020

  1. Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications

    Frontiers in Medicine, Vol. 7

  2. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2